GO:0048641 regulation of skeletal muscle tissue development: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048641 (regulation of skeletal muscle tissue development) is a biological process that modulates the frequency, rate or extent of skeletal muscle tissue development.
• Skeletal muscle development is orchestrated by myogenic regulatory factors (MRFs) such as MYOD1, MYF5, MYOG and MRF4, which are controlled by Pax3/Pax7 and other upstream regulators [1,3].
• Epigenetic mechanisms, including histone modifications (H3K27me3, acetylation) and microRNAs, are critical for regulating skeletal muscle development [5,7].
• Post-transcriptional regulation by RNA-binding proteins such as RBM24 modulates skeletal and cardiac muscle development, function and regeneration.
• Disruption of regulatory networks leads to skeletal muscle diseases, including muscular dystrophies, atrophy and rhabdomyosarcoma [1,3].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of regulatory genes in skeletal muscle development [1,3].
Description
Skeletal muscle tissue development is a highly coordinated process that gives rise to the contractile machinery essential for locomotion, posture and metabolism. The Gene Ontology (GO) term GO:0048641, regulation of skeletal muscle tissue development, encompasses any process that modulates the frequency, rate or extent of this developmental program [1,3]. Understanding how this regulation is achieved is fundamental to developmental biology and regenerative medicine, as perturbations underlie congenital myopathies, muscular dystrophies and age-related muscle wasting [1,3]. The process involves the specification of muscle progenitor cells, their proliferation, differentiation into myoblasts, and fusion into multinucleated myofibers, all controlled by a network of transcription factors, epigenetic modifiers and signaling pathways [1,3,5]. Research into GO:0048641 has been accelerated by single-cell technologies and CRISPR screens, which reveal the gene regulatory circuits driving muscle development. This article synthesizes current knowledge on the mechanisms, key genes and experimental models used to study the regulation of skeletal muscle tissue development.
regulation of skeletal muscle tissue development At A Glance
| GO ID | GO:0048641 |
|---|---|
| GO term | regulation of skeletal muscle tissue development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of skeletal muscle tissue development |
| Related processes | Myogenesis, muscle cell differentiation, satellite cell activation, muscle regeneration |
| Key regulators | MYOD1, MYF5, MYOG, MRF4, PAX3, PAX7, RBM24, epigenetic modifiers |
| Disease relevance | Muscular dystrophies, rhabdomyosarcoma, muscle atrophy, congenital myopathies |
What Is GO:0048641?
According to the Gene Ontology, GO:0048641 (regulation of skeletal muscle tissue development) is defined as any process that modulates the frequency, rate or extent of skeletal muscle tissue development. In other words, it includes all molecular and cellular events that control when, where and how strongly the developmental program of skeletal muscle is executed, without being the developmental process itself.
Why Is regulation of skeletal muscle tissue development Important in Cell Biology?
Regulation of skeletal muscle tissue development is critical for normal growth and for the regenerative capacity of muscle after injury. Disruption of this regulation leads to a spectrum of disorders, from developmental defects such as congenital muscular dystrophies to acquired conditions like cachexia and sarcopenia [1,3]. Moreover, understanding the regulatory mechanisms provides targets for therapeutic interventions in regenerative medicine and for improving meat production in livestock. The process is also a paradigm for studying how transcription factors, epigenetic marks and non-coding RNAs integrate to control cell fate decisions [5,7].
• Skeletal muscle is essential for movement, posture and whole-body metabolism.
• Regulation of muscle development determines muscle mass and function throughout life.
• Defects in regulatory genes cause congenital myopathies and muscular dystrophies.
• Muscle stem cells (satellite cells) rely on tight regulation for regeneration.
• Epigenetic regulation by H3K27me3 and acetylation controls myogenic gene expression [5,7].
• MicroRNAs fine-tune muscle development and are potential therapeutic targets.
• Post-transcriptional control by RBM24 is essential for muscle function and regeneration.
• Single-cell sequencing has revealed new regulatory cell populations in muscle.
• Understanding regulation aids in developing CRISPR therapies for muscle diseases [1,3].
• Livestock muscle development research benefits from regulatory insights.
What Happens During regulation of skeletal muscle tissue development?
Specification of muscle progenitor cells
In simple terms: The process begins by deciding which embryonic cells will become muscle.
During embryogenesis, signals from surrounding tissues induce the expression of paired-box transcription factors PAX3 and PAX7 in somitic cells, specifying them as muscle progenitors [1,3]. These progenitors then activate myogenic regulatory factors (MRFs) such as MYF5 and MYOD1, committing them to the myogenic lineage. The regulation of this step involves Wnt, Shh and BMP signaling pathways that modulate PAX3/7 activity.
Proliferation and differentiation of myoblasts
In simple terms: Muscle precursor cells multiply and then specialize.
Once specified, myoblasts proliferate under the control of growth factors like FGF and IGF-1. Upon differentiation cues, they exit the cell cycle and express MYOG (myogenin) and MRF4, which drive terminal differentiation. This transition is regulated by cell cycle regulators (e.g., p21, Rb) and by microRNAs such as miR-1 and miR-133.
Fusion into multinucleated myofibers
In simple terms: Specialized cells merge to form long muscle fibers.
Differentiated myocytes fuse with each other to form multinucleated myotubes, a process requiring cell membrane proteins (e.g., myomaker, myomerger) and cytoskeletal reorganization. This step is regulated by transcription factors like NFAT and by signaling pathways including Ca2+/calmodulin. The resulting myofibers mature and express contractile proteins such as myosin heavy chain.
Epigenetic regulation of myogenic gene expression
In simple terms: Chemical tags on DNA and histones control which muscle genes are turned on or off.
Histone modifications, such as H3K27me3 and acetylation, regulate the accessibility of myogenic loci [5,7]. The polycomb repressive complex 2 (PRC2) deposits H3K27me3 to silence non-muscle genes, while histone acetyltransferases (HATs) activate muscle-specific genes. DNA methylation and microRNAs also contribute to the epigenetic landscape.
Post-transcriptional control by RNA-binding proteins
In simple terms: RNA-binding proteins manage the stability and translation of muscle RNAs.
RBM24 is an RNA-binding protein that regulates alternative splicing and mRNA stability of genes involved in muscle development and function. Its depletion leads to defects in skeletal and cardiac muscle, highlighting the importance of post-transcriptional regulation in GO:0048641.
Key Genes Involved in GO:0048641 regulation of skeletal muscle tissue development
The following genes are central regulators of skeletal muscle tissue development, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAX3 | Specifies muscle progenitor cells | Marker of early myogenesis; mutations cause Waardenburg syndrome [1,3] |
| PAX7 | Maintains satellite cell pool | Key for muscle regeneration; target for regenerative therapies |
| MYF5 | Initiates myogenic commitment | First MRF expressed; knockout mice lack myoblasts |
| MYOD1 | Drives myoblast differentiation | Master regulator; converts fibroblasts to myoblasts |
| MYOG | Promotes terminal differentiation | Essential for myotube formation; knockout mice die at birth |
| MRF4 | Regulates late differentiation | Modulates myofiber phenotype; redundant with MYOG |
| MEF2C | Enhances MRF activity | Cooperates with MYOD1; regulates slow fiber genes |
| RBM24 | Post-transcriptional regulation | Controls splicing of muscle genes; knockout causes muscle defects |
| EZH2 | H3K27me3 deposition | Silences non-muscle genes; regulates proliferation |
| HDAC4 | Histone deacetylation | Represses MEF2; controls fiber type |
| MIR1-1 | MicroRNA | Promotes myogenesis; targets HDAC4 |
| MIR133A | MicroRNA | Regulates proliferation; targets SRF |
| IGF1 | Growth factor | Stimulates myoblast proliferation and differentiation |
| FGF2 | Growth factor | Inhibits differentiation; maintains progenitor state |
| MYH1 | Contractile protein | Marker of fast-twitch fibers; regulated by MRFs |
| ACTA1 | Actin | Major structural protein; mutations cause nemaline myopathy |
| TNNT3 | Troponin T | Regulates contraction; alternative splicing controlled by RBM24 |
| CREBBP | Histone acetyltransferase | Coactivator for MYOD1; regulates muscle gene expression |
How Is regulation of skeletal muscle tissue development Regulated?
The regulation of skeletal muscle tissue development is controlled by a multilayered network. At the transcriptional level, MRFs (MYOD1, MYOG, MYF5, MRF4) auto- and cross-regulate each other and are modulated by upstream factors like PAX3/7 and MEF2. Epigenetic modifiers, including histone acetyltransferases (e.g., CREBBP) and deacetylases (HDACs), as well as H3K27me3 writers (EZH2), dynamically alter chromatin accessibility [5,7]. MicroRNAs such as miR-1 and miR-133 fine-tune MRF expression and target components of signaling pathways. Post-transcriptional regulation by RBM24 affects mRNA stability and splicing of muscle genes. Signaling pathways, including IGF-1/PI3K/AKT/mTOR and TGF-beta/Smad, integrate external cues to modulate these regulators.
regulation of skeletal muscle tissue development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAX3 | Waardenburg syndrome, rhabdomyosarcoma | Knockout mouse, patient-derived iPSCs |
| MYOD1 | Muscle differentiation defects | Point mutation knock-in in C2C12 cells |
| ACTA1 | Nemaline myopathy | Knock-in mouse with ACTA1 mutation |
| RBM24 | Cardiomyopathy, muscle dysfunction | Conditional knockout zebrafish |
| EZH2 | Rhabdomyosarcoma, muscle atrophy | Overexpression in satellite cells |
Muscular dystrophies and congenital myopathies
Mutations in genes that regulate skeletal muscle development, such as those encoding MRFs or structural proteins, lead to muscular dystrophies and congenital myopathies. For example, mutations in ACTA1 cause nemaline myopathy, and defects in PAX7 impair satellite cell function, contributing to muscle degeneration [1,3].
Rhabdomyosarcoma
Rhabdomyosarcoma is a pediatric cancer that arises from impaired differentiation of muscle progenitor cells. Dysregulation of PAX3/7 and MRF activity, often through chromosomal translocations (e.g., PAX3-FOXO1), blocks terminal differentiation and promotes tumorigenesis.
Muscle atrophy and sarcopenia
Altered regulation of muscle development pathways contributes to muscle wasting in cancer cachexia, denervation and aging. For instance, increased expression of HDAC4 and myostatin inhibits myogenesis, while IGF-1 signaling promotes hypertrophy [1,7].
From regulation of skeletal muscle tissue development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate myoblast differentiation? | Knockout of gene X in C2C12 myoblasts |
| Does a point mutation in gene Y affect muscle development? | Point mutation knock-in in mouse zygotes |
| What is the effect of overexpressing gene Z on muscle mass? | Overexpression via AAV in mouse muscle |
| How does a tagged version of protein W localize in muscle cells? | Tagged knock-in (e.g., GFP) in zebrafish |
| Which enhancers control gene V expression? | CRISPR interference (CRISPRi) screen in myoblasts |
| Can we correct a disease-causing mutation in gene U? | CRISPR knock-in of wild-type allele in patient iPSCs |
How to Study the regulation of skeletal muscle tissue development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels and splicing | Identify differentially expressed genes during differentiation |
| scRNA-seq | Single-cell transcriptomes | Discover novel muscle progenitor populations |
| ChIP-seq | Histone modifications and TF binding | Map H3K27me3 and MYOD1 binding sites |
| ATAC-seq | Chromatin accessibility | Identify active enhancers in myoblasts |
| CLIP-seq | RNA-binding protein targets | Determine RBM24 target RNAs |
| Proteomics | Protein abundance and modifications | Quantify muscle structural proteins |
| CRISPR screen | Gene function at scale | Identify regulators of myoblast fusion |
Transcriptomic profiling
RNA-seq and single-cell RNA-seq reveal the gene expression programs during muscle development and identify novel regulators. These methods quantify mRNA levels and alternative splicing events, providing a snapshot of the regulatory state.
Epigenomic analysis
ChIP-seq for histone modifications (e.g., H3K27me3, H3K27ac) and ATAC-seq for chromatin accessibility map the regulatory landscape of myogenic genes [4,5]. These techniques identify enhancers and promoters controlled by MRFs and epigenetic modifiers.
Proteomic and post-transcriptional methods
Mass spectrometry-based proteomics quantifies protein abundance and modifications, while CLIP-seq for RNA-binding proteins like RBM24 identifies their target RNAs. These methods uncover post-transcriptional regulatory layers.
Functional perturbation
CRISPR-Cas9 knockout, CRISPRa/CRISPRi, and overexpression studies in cell culture and animal models test the causal role of candidate regulators [1,3]. Imaging of myotube formation and muscle contraction provides phenotypic readouts.
How CRISPR Can Be Used to Study GO:0048641 regulation of skeletal muscle tissue development
Knockout
CRISPR knockout of candidate regulatory genes (e.g., Pax7, Myod1) in myoblasts or mouse models ablates protein function, revealing essential roles in muscle development [1,3]. This approach is used to test whether a gene is required for myogenic differentiation or satellite cell maintenance.
Point Mutation
Introducing precise point mutations (e.g., in ACTA1 or MYOD1) via CRISPR base editing or HDR mimics human disease alleles, allowing study of their impact on muscle development and function. This is valuable for modeling congenital myopathies.
Knock-in
Knock-in of reporter tags (e.g., GFP) or disease-associated variants into endogenous loci enables visualization of protein localization and tracking of muscle progenitors in vivo. It also allows correction of mutations in patient-derived iPSCs for disease modeling.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of regulators like IGF1 or MYOD1 boosts muscle development and can ameliorate atrophy in disease models. This approach helps identify sufficiency of a gene to drive myogenesis.
How EDITGENE Supports regulation of skeletal muscle tissue development Research
Researchers studying regulation of skeletal muscle tissue development-related genes often need to determine whether a candidate gene is causally involved in myogenesis, regeneration or disease. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell and animal models, enabling functional validation of regulatory networks.
Contact EDITGENE today to design your custom CRISPR model for regulation of skeletal muscle tissue development research.
Frequently Asked Questions About regulation of skeletal muscle tissue development
What is GO:0048641?
GO:0048641 is the Gene Ontology term for regulation of skeletal muscle tissue development, defined as any process that modulates the frequency, rate or extent of skeletal muscle tissue development.
What genes are involved in regulation of skeletal muscle tissue development?
Key genes include PAX3, PAX7, MYF5, MYOD1, MYOG, MRF4, MEF2C, RBM24, EZH2, and microRNAs such as miR-1 and miR-133 [1,3,5,6,7].
How is skeletal muscle development regulated?
It is regulated by a network of transcription factors (MRFs), epigenetic modifiers, microRNAs, and signaling pathways like IGF-1/PI3K/AKT [1,5,7].
What diseases are associated with defects in skeletal muscle development regulation?
Muscular dystrophies, congenital myopathies, rhabdomyosarcoma, and muscle atrophy are linked to dysregulation of this process [1,3].
What is the role of PAX7 in muscle development?
PAX7 maintains the satellite cell pool and is essential for muscle regeneration after injury.
How do epigenetic modifications regulate muscle development?
Histone modifications such as H3K27me3 and acetylation control the accessibility of myogenic genes, thereby regulating differentiation [5,7].
What is the function of RBM24 in muscle?
RBM24 is an RNA-binding protein that regulates post-transcriptional processing of muscle genes, affecting development and function.
Can CRISPR be used to study skeletal muscle development?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable functional studies of regulatory genes in muscle cells and animal models [1,3].
What are the best cell models for studying muscle development?
C2C12 myoblasts, primary satellite cells, and patient-derived iPSCs are commonly used, along with zebrafish and mouse models [1,3].
How does single-cell sequencing help study muscle development?
Single-cell RNA-seq reveals cellular heterogeneity and identifies novel regulatory cell populations and gene networks during muscle development.
Conclusion
GO:0048641, regulation of skeletal muscle tissue development, is a fundamental biological process that integrates transcriptional, epigenetic, and post-transcriptional controls to build and maintain muscle tissue. Understanding its mechanisms is essential for deciphering muscle diseases and for developing regenerative therapies. With advanced CRISPR tools and multi-omics approaches, researchers can now dissect these regulatory networks with unprecedented precision.
References
- 1. Chargé SB et al.. 2004. Cellular and molecular regulation of muscle regeneration.. Physiol Rev 84(1):209-38 PMID: 14715915
- 3. Yin H et al.. 2013. Satellite cells and the muscle stem cell niche.. Physiol Rev 93(1):23-67 PMID: 23303905
- 4. Cai C et al.. 2023. Transcriptional and open chromatin analysis of bovine skeletal muscle development by single-cell sequencing.. Cell Prolif 56(9):e13430 PMID: 36855961
- 5. Gan YM et al.. 2019. [Histone H3K27me3 in the regulation of skeletal muscle development].. Yi Chuan 41(4):285-292 PMID: 30992250
- 6. Shi DL et al.. 2025. Rbm24-mediated post-transcriptional regulation of skeletal and cardiac muscle development, function and regeneration.. J Muscle Res Cell Motil 46(1):53-65 PMID: 39614020
- 7. Moresi V et al.. 2015. Regulation of skeletal muscle development and homeostasis by gene imprinting, histone acetylation and microRNA.. Biochim Biophys Acta 1849(3):309-16 PMID: 25598319
